Verastem | VSTM - Aset Lancar





Aset Lancar Perubahan Tanggal
AbbVie USD 33.53B 4.47B 2026-03
Alaunos Therapeutics USD 970K 1.02M 2026-03
AstraZeneca USD 29.61B 890M 2026-03
Curis USD 6.92M 7.5M 2025-12
Cytokinetics USD 839.46M 77.51M 2026-03
Gilead Sciences USD 18.64B 1.25B 2026-03
Incyte USD 5.48B 460.36M 2026-03
Laboratory Of America USD 4.56B 538.3M 2026-03
Novartis USD 26.61B 3.85B 2026-03
Pfizer USD 42.82B 76M 2026-03
Roche Holding CHF 38.73B 3.03B 2025-12
TG Therapeutics USD 1.09B 456.2M 2026-03
Verastem USD 223.41M 69.36M 2025-12